Charles R. (Chas) Eggert brings over 40 years of experience in the global specialty chemicals and food ingredients industries to the Board of CP Kelco. Eggert is an operating partner with iSelect Fund, a St. Louis-based venture capital firm investing in early stage agriculture, food, nutrition and wellness growth companies.

From 2014 to 2019, Eggert was an operating partner at Arsenal Capital Partners, a New York City-based private equity firm acquiring and building middle-market specialty chemical companies. While at Arsenal, he served as president and CEO of Solvaira Specialties, a food ingredients company owned by Arsenal. He also served as a Board Director at Arsenal portfolio companies Spartech LLC, Chroma Color Corporation and Meridian Adhesives Group.

From 2008 to 2014, Eggert was CEO and a board director of OPX Biotechnologies, Inc., a venture capital-financed company using biotechnology to produce chemicals from renewable raw materials. He joined OPX from AkzoNobel, where he was president of the Specialty Polymers Group. Eggert worked at the National Starch and Chemical Company of ICI PLC from 1999 to 2007 as Vice President of Personal Care and Vice President of Food Ingredients–Europe before being named Group Vice President of Specialty Polymers.

Eggert served as Vice President of Sales and Marketing with Engelhard Corporation from 1997 to 1999. He began his career with Monsanto Company, progressing over 20 years through roles with increasing responsibilities in technology, manufacturing, business development, marketing and general management.

Eggert is a Governance Fellow of the National Association of Corporate Directors. He is also a Board Director at Fathers and Families Support Center in St. Louis, Missouri. Additional prior Board Director positions include the American Chemistry Council, the Biotechnology Industry Organization and the Management Board of Huber Engineered Materials. He was a Founding Director and Chairman of the Colorado Cleantech Industry Association.

Eggert holds a BS in chemical engineering and an MBA from Washington University in St. Louis, as well as an MS in biochemical engineering from the University of Minnesota.